Metformin: Focus on Melanoma
Metformin is the most common biguanide used in the treatment of diabetes, with 120 million treated patients worldwide. Metformin decreases hyperglycemia without inducing hypoglycemia in diabetic patients and is very well tolerated. The principal effects of metformin are to decrease hepatic gluconeog...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018-08-01
|
| Serier: | Frontiers in Endocrinology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/article/10.3389/fendo.2018.00472/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|